OYLER JOHN (CIK 1042047) reported 209 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-12). Recent activity: Sell ONC (67 shares), Sell ONC (14,102 shares), Sell ONC (3,673 shares), Sell ONC (6,717 shares), Sell ONC (3,476 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 67 | $23,450 |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 14,102 | $5.1M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 3,673 | $1.3M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 6,717 | $2.4M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 3,476 | $1.2M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 12,418 | $4.4M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 15,869 | $5.7M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 2,813 | $989,603 |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 21,254 | $7.6M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 3,680 | $1.3M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 13,695 | $4.9M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 8,081 | $2.9M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 14,569 | $5.3M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 11,568 | $4.2M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 13,403 | $4.9M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 5,211 | $1.9M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 3,176 | $1.2M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,200 | $439,574 |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 4 | $1,468 |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,980 | $702,320 |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 2,515 | $896,426 |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 15,396 | $5.5M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 20,899 | $7.5M |
| 2026-08-12 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 45,044 | $16.2M |
| 2026-07-22 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 5,146 | $1.6M |
Source: SEC Form 4 filings · as of 2026-08-12